Last updated on June 2012

ANBL0032: Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue


Brief description of study

ANBL0032: Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue

Detailed Study Description

For more information please visit: http://clinicaltrials.gov/ct2/show/NCT00026312?term=ANBL0032&rank=1

Clinical Study Identifier: TX135885

Find a site near you

Start Over

Memorial Health University Medical Center

4700 Waters Avenue Hoskins Center - 2nd Floor Savannah, GA USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.